Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NHS warned over new corporate killing laws:

This article was originally published in Clinica

Executive Summary

The UK National Health Service (NHS) and other public bodies are being warned that they are unlikely to be exempt from proposed corporate killing legislation expected to be introduced during the present parliament. The warning comes from the British Safety Council, which says that four "tough laws" are set to replace the current "ineffective" law on involuntary manslaughter. The category of corporate killing aims to make companies accountable in criminal law for falling far below reasonable standards. The categories of reckless killing and killing by gross carelessness, address personal responsibility and carry prison terms of between 10 years and life. The proposed legislation comes at a time when the UK, among other countries, is seeking to introduce a blame-free culture among surgeons that commit errors (see Clinica No 966, p 7).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT072346

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel